Concepedia

Author

K Boggio

University of Turin

Also Known As

K Boggio, K. Boggio, Katia Boggio

16

Publications

1.1K

Citations

10

H-Index

30

Concepts

All Affiliations

University of TurinUniversity of Chieti-PescaraUniversity of BolognaUniversità di CamerinoFondazione IRCCS Istituto Nazionale dei Tumori
KB

About

K Boggio is an author at University of Turin specializing in immunology, medicine, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

211

2

Immunology

5

5

211

3

Cell Biology

3

3

162

4

Pathology

3

3

157

5

Autoimmunity

1

1

44

K Boggio

×

10

Publications

1.1K

Citations

10

H-Index

YearCitations

DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice  

Stefania Rovero, Augusto Amici, Emma Di Carlo,

The Journal of Immunology

2000

356

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/<i>neu</i> Transgenic Mice

K Boggio, Giordano Nicoletti, Emma Di Carlo,

The Journal of Experimental Medicine

1998

300

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

Claudia Curcio, Emma Di Carlo, Raphael Clynes,

Journal of Clinical Investigation

2003

119

Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.

Emma Di Carlo, Maria Grazia Diodoro, K Boggio,

PubMed

1999

107

Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice.

K Boggio, Emma Di Carlo, Stefania Rovero,

PubMed

2000

92

Insertion of the DNA for the 163–171 peptide of IL1β enables a DNA vaccine encoding p185neu to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice

Stefania Rovero, K Boggio, Emma Di Carlo,

Gene Therapy

2001

52

A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia.

Loredana Cifaldi, Elena Quaglino, Emma Di Carlo,

PubMed

2001

44

Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice.

Emma Di Carlo, Stefania Rovero, K Boggio,

PubMed

2001

39

Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas

Claudia Curcio, Emma Di Carlo, Raphael Clynes,

Journal of Clinical Investigation

2003

26

Cytokine gene-engineered vaccines.

G Forni, K Boggio

PubMed

1999

10

Page 1